Thank you to everyone who participated in the contest for a FREE ROOM giveaway at the iconic Boston Park Plaza! In addition to the insights and industry trends presented during the 17th Annual Cardiometabolic Health Congress (CMHC) - The Present and Future of Cardiometabolic Health: Insights and Expert Perspectives - TWO lucky winners earned a FREE room for a night ... Congratulations to CHAD D. CLARK, PA-C, and JOHN SCIALES, MD, the bona fide wicked smart WINNERS of the "Think You Know Boston?" quiz! Thanks again to everyone who participated; we hope to see everyone this Oct. 19-22 in Boston for the highly anticipated 17th Annual CMHC!
Labor Day Sale
There are no shortage of Labor Day sale offers, but the one from Cardiometabolic Health Congress (CMHC) is hands-down the most valuable! The generous discount we're offering on any LIVE EVENT from CMHC is sure to reap the rewards for years to come - the tools and strategies you'll take home will enhance the care you provide, improve your patients' outcomes, and boost your practice! Can you picture yourself on the Southern California landscape this September at the Terranea Resort, or experiencing an East Coast Autumn while staying at the Boston Park Plaza this October? Use code LABORDAYWEEK40 to automatically take 40% off the price of CMHC's Women's Cardiometabolic Health and Wellness Masterclass in Rancho Palos Verdes OR the 17th Annual Congress in Downtown Boston.**
Do your patients, your practice, and your clinical toolkit a favor by attending one of CMHC's conferences at an incredible discount!
**Code LABORDAYWEEK40 can be used at checkout to instantly save 40% on any live CMHC event. Discount is not valid on previous purchases, cannot be combined with other offers, and is not redeemable for cash. Limit one use per customer, per transaction. Offer expires at 11:59 p.m. EST on Monday, Sept. 5, 2022.
Clinical Case - NEW!
The research data, clinical evidence, and practical strategies presented in CMHC's educational events have a purpose: to be applied in your practice with the goal of improving and lengthening your patients' lives. Let's dive into September's clinical case, first presented at CMHC's Spring 2022 Congress in Scottsdale by Holly R. Wyatt, MD. Here are the details of Dr. Wyatt's patient case:
32-year old female
Weight 195 lbs, height 5 ft 10 inches, BMI = 28
Waist circumference 35 inches
Married with two children, husband is overweight
Reports weight gain of 2-3 lbs per year
She weighed 175 lbs at 22 and 185 lbs at 26
Family history: Father died at 47 from a heart attack while playing tennis, mother is healthy, no other family history of cardiovascular disease
No personal history of heart problems or chest pain
She is on no medications
The only remarkable finding on exam is an elevated systolic blood pressure of 135/72 mmHg
EKG is normal
Labs are within normal limits except: TG 165 mg/dl, HDL 45 mg/dl, HA1C 6.0%
A recent workup of her heart reveals no detectable cardiovascular disease
Based on this presentation, what lifestyle interventions can be initiated to optimize the outcomes for Dr. Wyatt's patient?
Lose weight (5%-10%)
Stop the weight gain (maintain current weight)
Change the quality of her diet
Increase her activity level
Decrease her sedentary activity
Do nothing at this point
Listen to CMHC's expert panel discuss Dr. Wyatt's patient and share their decision-making strategies on stage at the Spring 2022 Congress, learn which option Dr. Wyatt chose, and see the 3-month follow-up results for this patient.
Tune into a special Cardiometabolic Beat Podcast Series: Management of CKD in Patients with Type 2 Diabetes, a five-part exploration of topics vital for any provider who deals with the intersection of diabetes and kidney disease. Listen to all five episodes on Apple, Spotify, or watch on YouTube:
The U.S. Food and Drug Administration (FDA) has expanded its approval of the Omnipod 5, a tubeless, hybrid closed-loop insulin delivery system from Insulet Corporation for pediatric patients two years and older with type 1 diabetes. Omnipod 5 was the first tubeless automated insulin delivery (AID) system approved for use in the U.S. It was originally cleared for use in children six years and older in January 2022. Read the press release here, and for more advancements on the treatment and management of the full spectrum of pediatric cardiometabolic diseases, including diabetes, attend Addressing Cardiometabolic Risk in Children and Adolescents TOMORROW, Sept. 2, at Disney's Yacht and Beach Club Resorts.
Partner Spotlight
Low Dose Naltrexone (LDN) holds the potential to help millions of people with autoimmune diseases and cancers, and even those with autism, chronic fatigue, and depression. Administered off-label in small daily doses (0.5 to 4.5 mg), this generic drug is extremely affordable and presents few known side effects. So why has it languished in relative medical obscurity? Find out more about this safe, non-toxic, and inexpensive drug that helps regulate a dysfunctional immune system HERE.
